Op-Ed on Failed Biden COVID Strategy Eludes the Censors

The Washington Times published an interesting op-ed on vaccines and the Biden Administration’s (mis)use of them. I’m not totally sold on all of the points presented, but it certainly makes some interesting arguments which are worthy of consideration. The op-ed carries a little extra weight because it was co-written by Dr. Robert Malone. Dr. Malone is literally one of the key inventors of the mRNA vaccine technology. So the left’s standard procedure of denouncing him as “anti-science” and a spreader of “misinformation” doesn’t really work. Instead, they are borrowing from the old Soviet Union playbook and attempting to erase him from history altogether. Lefties are nothing if not predictable.

As for what this all means politically, I think Biden and the Democrats are in deep doo-doo come 2022. The next election is still a long ways off, but polls show Biden is underwater on almost every issue except his handling of the COVID pandemic. I think that is going to come crashing down on him big time. And sooner, rather than later. In the debates, Trump was for a return to normalcy. Biden said we couldn’t have normalcy until we “defeated” the virus. And swore he was the only candidate that could do it. However, it is sure starting to look like the coronavirus is here to stay. Between “leaky” vaccines and multiple new variants, the coronavirus appears set to join influenza and the common cold as perennial scourges on humanity (thanks, Fauci!!!) With no hope of “victory” over COVID, Biden’s big-stuffing in the debates will be exposed as the vain bluster of a befuddled imbecile, and his draconian countermeasures will be seen in a much less favorable light. (The Administration knows this. Which is why they are already trying to deflect blame on to Red State governors and the unvaccinated.) Successfully pinning a (un)natural disaster on the incumbent was a large part of how the Democrats weaseled their way back into power. It’s about to get thrown back in their smug faces.